Unlocking novel therapeutic avenues in glioblastoma: Harnessing 4-amino cyanine and miRNA synergy for next-gen treatment convergence
K Sandhanam,
No information about this author
Tamilanban Thamaraikani,
No information about this author
K. Manasa
No information about this author
et al.
Neuroscience,
Journal Year:
2024,
Volume and Issue:
553, P. 1 - 18
Published: June 27, 2024
Language: Английский
Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint
Life Sciences,
Journal Year:
2024,
Volume and Issue:
342, P. 122509 - 122509
Published: Feb. 22, 2024
Language: Английский
Molecular insights into cell signaling pathways in kidney stone formation
Urolithiasis,
Journal Year:
2025,
Volume and Issue:
53(1)
Published: Feb. 14, 2025
Language: Английский
Quantitative real-time PCR analysis of circulating MicroRNA levels in blood samples from pediatric patients with epilepsy
Gene Reports,
Journal Year:
2025,
Volume and Issue:
unknown, P. 102214 - 102214
Published: April 1, 2025
Language: Английский
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA
Haotian Chen,
No information about this author
Jing Wen,
No information about this author
Wentao Zhang
No information about this author
et al.
iScience,
Journal Year:
2024,
Volume and Issue:
27(4), P. 109624 - 109624
Published: March 29, 2024
Circular
RNAs
(circRNAs)
play
crucial
biological
functions
in
various
tumors,
including
bladder
cancer
(BCa).
However,
the
roles
and
underlying
molecular
mechanisms
of
circRNAs
malignant
proliferation
BCa
are
yet
unknown.
CircKDM1A
was
observed
to
be
downregulated
tissues
cells.
Knockdown
circKDM1A
promoted
cells
xenograft
growth,
while
overexpression
exerts
opposite
effect.
The
dual-luciferase
reporter
assay
revealed
that
directly
bound
miR-889-3p,
acting
as
its
sponge
downregulate
CPEB3.
In
turn,
CPEB3
CPE
signal
p53
mRNA
3'UTR
stabilize
expression.
Thus,
circKDM1A-mediated
downregulation
inhibits
stability
promotes
progression.
conclusion,
a
tumor
suppressor
via
miR-889-3p/CPEB3/p53
axis.
may
potential
prognostic
biomarker
therapeutic
target
BCa.
Language: Английский
Decoding Kidney Pathophysiology: Omics-Driven Approaches in Precision Medicine
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1157 - 1157
Published: Dec. 19, 2024
Chronic
kidney
disease
(CKD)
is
a
major
worldwide
health
concern
because
of
its
progressive
nature
and
complex
biology.
Traditional
diagnostic
therapeutic
approaches
usually
fail
to
account
for
heterogeneity,
resulting
in
low
efficacy.
Precision
medicine
offers
novel
approach
studying
by
combining
omics
technologies
such
as
genomics,
transcriptomics,
proteomics,
metabolomics,
epigenomics.
By
identifying
discrete
subtypes,
molecular
biomarkers,
targets,
these
pave
the
way
personalized
treatment
approaches.
Multi-omics
integration
has
enhanced
our
understanding
CKD
revealing
intricate
linkages
pathways
that
contribute
resistance
progression.
While
pharmacogenomics
insights
into
expected
responses
treatments,
single-cell
spatial
transcriptomics
can
be
utilized
investigate
biological
heterogeneity.
Despite
significant
development,
challenges
persist,
including
data
concerns,
high
costs,
ethical
quandaries.
Standardized
protocols,
collaborative
data-sharing
frameworks,
advanced
computational
tools
machine
learning
causal
inference
models
are
required
address
challenges.
With
advancement
technology,
nephrology
may
benefit
from
improved
accuracy,
risk
assessment,
care.
overcoming
barriers,
precision
potential
develop
techniques
improving
patient
outcomes
treatment.
Language: Английский
Exosomes in renal cell carcinoma: challenges and opportunities
Molecular Biology Reports,
Journal Year:
2024,
Volume and Issue:
51(1)
Published: March 23, 2024
Language: Английский
Regulation of B-cell function by miRNAs impacting Systemic lupus erythematosus progression
Bevan E. Huang,
No information about this author
Fengbiao Guo,
No information about this author
Jiaxuan Chen
No information about this author
et al.
Gene,
Journal Year:
2024,
Volume and Issue:
933, P. 149011 - 149011
Published: Oct. 18, 2024
Systemic
lupus
erythematosus
(SLE)
is
a
complex
autoimmune
disease
marked
by
abnormal
B-cell
proliferation
and
increased
autoantibodies.
miRNAs
play
crucial
role
in
regulating
dysfunction
SLE
pathology.
influence
DNA
methylation,
activation,
gene
expression,
contributing
to
pathogenesis.
impact
B
cells
through
key
processes
like
proliferation,
differentiation,
tolerance,
apoptosis.
also
exacerbate
inflammation
immune
responses
modulating
Interleukin
4
(IL-4),
IL-6,
interferon
cytokines.
Autophagy,
degradation
mechanism,
regulated
specific
that
This
article
explores
the
of
multiple
development,
survival,
responses,
influencing
miR-23a,
miR-17
∼
92
family,
miR-125b/miR-221
affect
development
transcription
factors,
signaling
pathways,
cell
cycle
genes.
such
as
miR-181a-5p
miR-23a-5p
are
differentially
across
developmental
stages,
emphasizing
their
regulatory
roles
biology.
synthesizes
miRNA-B
interactions
offer
new
strategies
directions
for
diagnosis
treatment.
Language: Английский